FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.
Oh boy, another day, another snag. There goes our Christmas bonus, dang.
LIVE QUOTE
It's been a gut wrenching couple years for shareholders. Is it big...
Scalpers Get Scalped!
Go Big or go Home. SEC Charges Eight Social Media Influencers in $100 Million Profit Stock Scheme.
SEC Charges Eight Social Media Influencers in $100...
Adding Unicycive (UNCY) $0.75 to the Watch List.
Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is a biotech...
Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.
After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process.
Lightly traded (400,000...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude.
We...
Silo Pharma (SILO) Issues Letter to Shareholders
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
LIVE QUOTE
ENGLEWOOD CLIFFS, NJ, Dec. 01, 2022 (GLOBE...
Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
New Report Coming, Sign up to our Newsletter for Priority Notification.
Absolutely banging numbers, we view Smart for Life (SMFL) as a company which...
Smart for Life (SMFL) Reports, Headlines and More.
Smart For Life Corporate Investor Center
2022, 28-11. ($0.40) Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
2022, 10-21. ($0.41). Smart for Life Appoints...
Provention Bio (PRVB) Gains 26% Last Week.
We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm Down, Let's...
FDA Approves Most Expensive Drug Ever, @ $3.5 Million-Per-Dose, from uniQure (QURE).
Important to note, the FDA didn't approve the price, they approved the drug. It was priced afterwards. Second item it is a one-time treatment.
FDA...
Latest article
United States Antimony (UAMY) on Fox News.
DALLAS, TX / ACCESS Newswire / June 4, 2025 / United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE American: UAMY), announced today that its Chairman...
Institutional Analyst: Latest Newsletter.
Biotechnology, Beverages, Precious Metals, Psychedelics, and Technology.
Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources...
Blue Ocean Equities Report on Antimony.
Antimony Macro Note: Don’t expect Sb prices to pull back anytime soon!
ANTIMONY MACRO NOTE
On Gold Investment Conference
A simply fantastic report (best in world) though...
